Top Story

Rhopressa fails to meet primary efficacy endpoint of non inferiority to timolol

April 24, 2015

Despite failing to meet its primary endpoint of non-inferiority to timolol, the glaucoma medication Rhopressa compared well with timolol on most key metrics, according to Vincente Anido Jr., PhD, chairman and CEO of Aerie Pharmaceuticals.

Anido delivered 90-day efficacy results of the initial phase 3 Rocket 1 clinical trial during a company-sponsored conference call.

John A. Hovanesian Blog

BLOG: Approval of near vision inlay — A huge step forward

April 24, 2015
The biggest news at ASCRS was the FDA’s approval of the AcuFocus Kamra inlay for correction of presbyopia. This is an enormous advance in patient care, bringing to the…
VIDEO: Surgeon gives pearls for improving glued IOL outcomes Meeting News CoverageVideo

VIDEO: Surgeon gives pearls for improving glued IOL outcomes

April 24, 2015
SAN DIEGO ― At the American Society of Cataract and Refractive Surgery meeting here, Ashvin Agarwal, MD, discusses strategies and techniques for improving outcomes for…
Study: Corneas from older donors suitable for transplantation Meeting News Coverage

Study: Corneas from older donors suitable for transplantation

April 24, 2015
SAN DIEGO — Corneas from donors between the ages of 76 years and 85 years were suitable for transplantation, according to a study presented at the World Cornea…
VIDEO: Femtosecond laser cataract surgery platform improvements moving procedure forward Meeting News CoverageVideo

VIDEO: Femtosecond laser cataract surgery platform improvements moving procedure forward

April 24, 2015
SAN DIEGO ― At the American Society of Cataract and Refractive Surgery meeting here, Robert Weinstock, MD, discusses the latest advances and improvements in different…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »
CME
Challenges and Solutions in Retinal Vascular Disease: Pigment Epithelial Detachment and Refractory Diabetic Macular Edema

Challenges and Solutions in Retinal Vascular Disease: Pigment Epithelial Detachment and Refractory Diabetic Macular Edema

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

With anti-VEGF therapy well-established as front-line therapy in the management of age-related macular degeneration and…
More »
Meeting News Coverage Video
VIDEO: Femtosecond laser cataract surgery platform improvements moving procedure forward

VIDEO: Femtosecond laser cataract surgery platform improvements moving procedure forward

April 24, 2015
SAN DIEGO ― At the American Society of Cataract and Refractive Surgery meeting here, Robert Weinstock, MD,
More »
morganatic-roan